-Robin Kelly Researcher Activity Profile

Research Author Detailed Information 

Robin Kelly Publication Rate By Year

Robin Kelly has published 1 paper(s) in 1989, 1 paper(s) in 2006, 8 paper(s) in 2007, 9 paper(s) in 2008, for a total of 19 research publications in total.

Robin R Kelly Author Information

LAST NAME: kelly

FIRST NAME: Robin

INITIALS: r

AFFILIATION:

Papers

Robin Kelly's Publication Record

1. Buffering airway acid decreases exhaled nitric oxide in asthma. Year Published: 2006
Department of Pediatric Respiratory Medicine, The University of Virginia School of Medicine, Charlottesville, VA 22908, USA. bmg3g@virginia.edu
2. Fgf10 dosage is critical for the amplification of epithelial cell progenitors and for the formation of multiple mesenchymal lineages during lung development. Year Published: 2007
Developmental Biology Program, Saban Research Institute of Childrens Hospital Los Angeles, Los Angeles, CA 90027, USA.
3. Patterns of participation of patients in cancer clinical trials in Ireland. Year Published: 2007
Cancer Clinical Trials Office, Cancer Centre, Beaumont Hospital, Dublin 9, Ireland, p_ob1_morris@yahoo.com.
4. Tolerization with BLP down-regulates HMGB1 a critical mediator of sepsis-related lethality. Year Published: 2007
Department of Academic Surgery, University College Cork (UCC)/National University of Ireland (NUI), Cork University Hospital, Cork, Ireland.
5. Antibacterial Oxazolidinones Possessing a Novel C-5 Side Chain. (5R)-trans-3-[3-Fluoro-4- (1-oxotetrahydrothiopyran-4-yl)phenyl]-2- oxooxazolidine-5-carboxylic Acid Amide (PF-00422602), a New Lead Compound. Year Published: 2007
Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48105.
6. Patterns of participation of patients in cancer clinical trials in Ireland. Year Published: 2007
Cancer Clinical Trials Office, Cancer Centre, Beaumont Hospital, Dublin 9, Ireland. p_ob1_morris@yahoo.com
7. Tolerization with BLP down-regulates HMGB1 a critical mediator of sepsis-related lethality. Year Published: 2007
Department of Academic Surgery, University College Cork (UCC)/National University of Ireland (NUI), Cork University Hospital, Cork, Ireland.
8. Antibacterial oxazolidinones possessing a novel C-5 side chain. (5R)-trans-3-[3-Fluoro-4- (1-oxotetrahydrothiopyran-4-yl)phenyl]-2- oxooxazolidine-5-carboxylic acid amide (PF-00422602), a new lead compound. Year Published: 2007
Michigan Laboratories, Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105, USA.
9. Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism. Year Published: 2008
Department of Discovery Immunology, Biogen Idec, Cambridge, Massachusetts 02142, USA.
10. Patterns of participation of patients in cancer clinical trials in Ireland. Year Published: 2007
Cancer Clinical Trials Office, Cancer Centre, Beaumont Hospital, Dublin 9, Ireland. p_ob1_morris@yahoo.com
11. Liver packing: a variation of an old technique. Year Published: 2008
Department of Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA. aong@wpahs.org
12. Liver packing: a variation of an old technique. Year Published: 2008
Department of Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA. aong@wpahs.org
13. Rapid diagnosis of Aujeszky's disease in pigs by improved in situ hybridization using biotinylated probes on paraffin-embedded tissue sections. Year Published: 1989
14. Measurement of drug agglomerates in powder blending simulation samples by near infrared chemical imaging. Year Published: 2008
Product Development, Johnson & Johnson Pharmaceutical Research & Development, LLC, Welsh & McKean Roads, Spring House, PA 19477, United States.
15. Stable computed-torque control of robot manipulators via fuzzy self-tuning. Year Published: 2008
Inst. Tecnologico de la Laguna.
16. Liver packing: a variation of an old technique. Year Published: 2008
Department of Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA. aong@wpahs.org
17. Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism. Year Published: 2008
Department of Discovery Immunology, Biogen Idec, Cambridge, Massachusetts 02142, USA.
18. Cefprozil versus Cefuroxime Axetil in the Treatment of Acute Sinusitis. Year Published: 2008
Oshawa Clinic, Oshawa, Ontario, Canada.
19. Localization and fate of Fgf10-expressing cells in the adult mouse brain implicate Fgf10 in control of neurogenesis. Year Published: 2008
School of Biological Sciences, University of East Anglia, Norwich NR4 7TJ, UK.